UNIVERSITY OF CANNABIS MEDICINE
DEAD

Serial Number

87522903

Owner

University of Cannabis Medicine Inc..

Filing Date

Jul 11, 2017

Add to watchlist:

No watchlists yet
View on USPTO

UNIVERSITY OF CANNABIS MEDICINE Trademark

Serial Number: 87522903

UNIVERSITY OF CANNABIS MEDICINE is a trademark filed by University of Cannabis Medicine Inc.. on July 11, 2017. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

University of Cannabis Medicine Inc..

603 Gordon st
Moosomin 1182 , CA

Entity Type: 03

Trademark Details

Filing Date

July 11, 2017

Registration Date

Not Registered

Goods & Services

College consulting services, namely, assisting students in finding colleges and universities and completing the application process; College counseling services, namely, assisting students who struggle academically due to learning disabilities in finding colleges and universities and completing the application process; Educating at university or colleges; Educational services, namely, conducting distance learning instruction at the university level; Educational services, namely, conducting distance learning instruction at the primary and secondary levels; Educational services, namely, conducting distance learning instruction at the secondary, college and graduate levels; Educational services, namely, conducting distance learning instruction at the University level; Educational services, namely, online training in connection with all aspects of the federal government's Universal Service Fund Program for Schools and Libraries; Providing a web site that features information on attending college and university with an emphasis on newly enrolled students

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Providing independent review of clinical trials for business purposes; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs

Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research

Clinical research in the field of Cannabis Medicine; Conducting clinical trials for others; Conducting clinical trials for others in the field of Cannabis Medicine; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services for others in the field of design, planning, and implementation project management of Medical Cannabis Product Development.; Medical and scientific research, namely, conducting clinical trials for others; Providing a website featuring educational information in the field of clinical research; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sep 23, 2019 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 23, 2019 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 25, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 25, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 25, 2019 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 22, 2019 RCCK
ASSIGNED TO LIE
Feb 11, 2019 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 25, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 25, 2018 GNSL
SUSPENSION LETTER WRITTEN
Jul 25, 2018 CNSL
EXAMINER'S AMENDMENT ENTERED
Jul 25, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 25, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 25, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 25, 2018 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 26, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jan 26, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jan 26, 2018 CNRT
ASSIGNED TO EXAMINER
Jan 23, 2018 DOCK
ASSIGNED TO EXAMINER
Jul 17, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2017 NWOS
NEW APPLICATION ENTERED
Jul 14, 2017 NWAP